Form 8-K - Current report:
SEC Accession No. 0001213900-25-006105
Filing Date
2025-01-24
Accepted
2025-01-23 19:05:59
Documents
19
Period of Report
2025-01-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0228576-8k_klotho.htm   iXBRL 8-K 34964
2 FORM OF PURCHASE AGREEMENT ea022857601ex4-1_klotho.htm EX-4.1 259851
3 FORM OF NOTE ea022857601ex4-2_klotho.htm EX-4.2 273767
4 FORM OF WARRANT ea022857601ex4-3_klotho.htm EX-4.3 123307
5 FORM OF REGISTRATION RIGHTS AGREEMENT ea022857601ex4-4_klotho.htm EX-4.4 108381
6 FORM OF VOTING AGREEMENT ea022857601ex4-5_klotho.htm EX-4.5 47224
  Complete submission text file 0001213900-25-006105.txt   1276596

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE klto-20250123.xsd EX-101.SCH 3497
8 XBRL DEFINITION FILE klto-20250123_def.xml EX-101.DEF 26516
9 XBRL LABEL FILE klto-20250123_lab.xml EX-101.LAB 36424
10 XBRL PRESENTATION FILE klto-20250123_pre.xml EX-101.PRE 25140
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0228576-8k_klotho_htm.xml XML 5482
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Klotho Neurosciences, Inc. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 25551294
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)